These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7736635)

  • 1. Treatment of genital HPV-infections with natural alpha interferon from normal human leucocytes.
    Zarcone R
    Clin Exp Obstet Gynecol; 1995; 22(1):14-9. PubMed ID: 7736635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical interferon for HIV-positive women.
    Posit Aware; 1995; ():5-6. PubMed ID: 11362668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local therapy and adjuvant interferon therapy in genital papilloma virus infections].
    Backe J; Roos T; Kaesemann H; Martius J; Ott M
    Gynakol Geburtshilfliche Rundsch; 1995; 35(2):79-84. PubMed ID: 7620386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [HPV genital infections + CIN. The immunological patterns, loop electroablation and beta-interferon].
    Vitale G; Linciano M; Salamanca S; Ferrari P
    Minerva Ginecol; 1994 Mar; 46(3):91-4. PubMed ID: 8015705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intramuscular beta-interferon in the treatment of cervical intraepithelial neoplasia (CIN) associated with human papilloma virus (HPV) infection].
    Grio R; Porpiglia M; Piacentino R; Marchino GL
    Minerva Ginecol; 1994 Oct; 46(10):579-82. PubMed ID: 7838417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topic and systemic administration of natural alfa interferon in the treatment of female and male HPV genital infections.
    Stentella P; Frega A; Di Renzi F; Palazzetti PL; Pachì A
    Clin Exp Obstet Gynecol; 1996; 23(1):29-36. PubMed ID: 8653931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The diagnosis and therapy of HPV-associated genital lesions: the role of systemic beta-interferon treatment].
    Mojana G; Carinelli S; Borroni R; Buonaguidi A; Luzzu A; Milesi M
    Minerva Ginecol; 1995; 47(1-2):31-7. PubMed ID: 7770146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathology of the lower genital tract].
    Tisné J; Briones H; Castro L; Osorio O; Segovia S
    Rev Chil Obstet Ginecol; 1993; 58(5):339-48. PubMed ID: 7991854
    [No Abstract]   [Full Text] [Related]  

  • 9. High risk HPV persists after treatment of genital papillomavirus infection but not after treatment of cervical intraepithelial neoplasia.
    Strand A; Wilander E; Zehbe I; Rylander E
    Acta Obstet Gynecol Scand; 1997 Feb; 76(2):140-4. PubMed ID: 9049287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology case of the month. A 35-year-old woman with an abnormal pap smear. HR-HPV-DNA positive atypical aquamous cells of undetermined significance (ASCUS).
    Latif S; Veillon DM; Matthews-Greer J; Cotelingam JD; Turbat-Herrera EA
    J La State Med Soc; 2005; 157(2):77-9. PubMed ID: 16022272
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta interferon in clinical practice].
    Struzziero E; Corbo M
    Minerva Ginecol; 1994 Sep; 46(9):487-9. PubMed ID: 7984328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer, human papillomavirus and vaccines.
    Khan SA
    Clin Oncol (R Coll Radiol); 1993; 5(6):386-90. PubMed ID: 8305362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent human papillomavirus infection and smoking increase risk of failure of treatment of cervical intraepithelial neoplasia (CIN).
    Acladious NN; Sutton C; Mandal D; Hopkins R; Zaklama M; Kitchener H
    Int J Cancer; 2002 Mar; 98(3):435-9. PubMed ID: 11920596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 17: Genital human papillomavirus infections--current and prospective therapies.
    Stanley M
    J Natl Cancer Inst Monogr; 2003; (31):117-24. PubMed ID: 12807955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alfa-2b for treatment of subclinical intraurethral human papilloma virus infection.
    Harrison RH
    Urology; 1997 Aug; 50(2):317. PubMed ID: 9255317
    [No Abstract]   [Full Text] [Related]  

  • 16. Toward a human papillomavirus vaccine.
    Rowen D; Lacey C
    Dermatol Clin; 1998 Oct; 16(4):835-8. PubMed ID: 9891690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of gynaecological high-risk human papilloma virus infection with human leukocyte ultrafiltrate.
    Spitzbart H; Hoyme UB
    Infect Dis Obstet Gynecol; 2000; 8(3-4):120-3. PubMed ID: 10968593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoprevention and vaccines: a review of the nonsurgical options for the treatment of cervical dysplasia.
    Bell MC; Alvarez RD
    Int J Gynecol Cancer; 2005; 15(1):4-12. PubMed ID: 15670290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HIV, HPV and cervical pathology].
    Quéreux C; Bory JP
    Contracept Fertil Sex; 1997 Feb; 25(2):120-4. PubMed ID: 9116771
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and clinical management of cervical HPV infections].
    Carcopino X; Camus C; Halfon P
    Presse Med; 2015; 44(7-8):716-26. PubMed ID: 26067573
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.